Aldeyra Therapeutics to Host R&D Day on Tuesday, March 29, 2022
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that it will host a Research & Development Day from 10:00 a.m. to 12:30 p.m. ET on Tuesday, March 29, 2022 in New York City. Aldeyra will announce top-line data from the Phase 2 proof-of-concept clinical trials of ADX-629, a first-in-class orally administered RASP modulat